акш. Министерство Здравоохранения Российской Федерации Российское общество кардиосоматической реабилитации и вторичной
 Скачать 1.05 Mb.
|
|
Diabetes. 2003; 52: 2814–20. 178 153. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34 (28): 2159-219. 154. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Eng J Med 2002; 347: 1309–17. 155. Mannacio VA, Di Tommaso L, Antignan A, De Amicis V, Vosa C. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study. Heart. 2012; 98: 1710–5. doi: 10.1136/heartjnl-2012-302449. 156. Mariani A.M., Gu J., Boonstra P.W., et al. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann. Thorac. Surg. 1999; 67: 1370–5. 157. Mariscalco G., Lorusso R., Klersy C. et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg. 2007; 84:1158-64. 158. Mariscalco G, Klersy C, Zanobini M, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 2008;118:1612–8. 159. Martins GF, Siqueira Filho AG, Santos JB, Assungao CR, Bottino F, Carvalho KG, Valencia A. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting. Arq Bras Cardiol. 2011; 97(3): 209-16. 160. Martin F. Recognizing depression after a coronary artery bypass graft. Br J Nurs. 2006;15:703– 6. 161. Mazzali G, Fantin F, Zoico E et al. Heart Fat Infiltration In Subjects With and Without Coronary Artery Disease. J Clin Endocrinol Metab. 2015;100 (9): 3364-71. 162. Mehta R.H., Bhatt D.L., Steg P.G. et al. REACH Registry Investigators Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur. Heart. J. 2008; 29: 3052-60. doi: 10.1093/eurheartj/ehn478. 179 163. Mehta RH, Sheng S, O’Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes. 2009; 2: 583–90. 164. Men E., Yildirimturk O., Tugcu A. et al. The comparison between the efficiency of different anti–arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery. Anadolu Kardiol Derg. 2008; 8(3): 206–12. 165. Miceli A, Capoun R, Fino C, et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2009; 54:1778–84. 166. Mittleman MA, Maclure M, Glasser DB. Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate. Am JCardiol. 2005; 96: 443-6. 167. Moholdt T, Bekken Vold M, Grimsmo J, Slørdahl SA, Wisløff U. Home-based aerobic interval training improves peak oxygen uptake equal to residential cardiac rehabilitation: a randomized, controlled trial. PLoS One. 2012; 7 (7): e41199. 168. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomized, clinical SYNTAX trial. Lancet. 2013; 381: 629-38. 169. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease Eur Heart J 2013; doi:10.1093/eurheartj/eht296. 170. Morkedal B. Metabolically healthy obesity confers excess risk for HF, but not acuta MI. J Am Coll Cardiol. 2014; doi:10.1016/j.jacc.2013.11.035. 171. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998; 97:916–31. 172. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601- 13. 173. Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, Wallace S. for the ATACAS Investigators of the ANZCA Clinical Trials Network. Stopping vs. Continuing Aspirin before Coronary Artery Surgery. N Engl J Med. 2016; 374: 728-37. doi: 10.1056/NEJMoa1507688. 180 174. Nashef SA, Mackenzie M. Sexual function after coronary surgery. BMJ 1991;302: 724. 175. Nicolosi A, Moreira ED Jr, Villa M, Glasser DB. A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men. J Affect Disord. 2004; 82: 235–43. 176. Oosterga M., Voors A.A., Pinto Y.M. et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol. 2001; 87 (5): 542-6. 177. Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103: 687–94. 178. Ouattara A, Benhaoua H, Le Manach Y, Mabrouk-Zerguini N, Itani O, Osman A, Landi M, Riou B, Coriat P. Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery.J Cardiothorac Vasc Anesth. 2009;2 3: 633–8. doi: 10.1053/j.jvca.2009.02.008. 179. Quin PR, Goel K, Lahr BD. et al. Participation in cardiac rehabilitation and survival after coronary artery bypass graft surgery: a community-based study. Circulation. 2013; 128 (6): 590-7. 180. Quittan M, Wiesinger GF, Sturm B, Puig S, Mayr W, Sochor A, Paternostro T, Resch KL, Pacher R, Fialka-Moser V. Improvement of thigh muscles by neuromuscular electrical stimulation in patients with refractory heart failure: a single-blind, randomized, controlled trial.Am J Phys Med Rehabil. 2001; 80(3): 206-14. 181. Padma-Nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F. A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002; 60 (suppl 2): 67–90. 182. Patti G., Chello M., Cadura D. et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the Armyda-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006; 114:1455-61. 183. Perk J, Alexanderson K. Sick leave due to coronary artery disease or stroke. Scand J Public Health. 2004; 32: 181–206. 181 184. Philip F, Blackstone E, Kapadia SR. Impact of statins and beta-blocker therapy on mortality after coronary artery bypass graft surgery Cardiovasc Diagn Ther. 2015; 5(1): 8-16. 185. Piepoli MF, Hoes AW, Agewall S, et al., 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016 doi:10.1093/eurheartj/ehw106. 186. Piper SN, Kumle B, Maleck WH, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth. 2003; 50:285–92. 187. Pitt B., Zannad F., Remme W.J., et al. for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999; 341: 709-17. 188. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; doi:10.1093/eurheartj/ehw128. 189. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, Staples JR, Glas KE, Marshall JJ, Leimbach ME, McCall SA, Petersen RJ, Bailey DE, WeintraubWS, Guyton RA. Off-pumpvs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA J Am Med Assoc. 2004; 291: 1841–9. 190. Raja SG, Fida N. Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation? Interact Cardiovasc Thorac Surg. 2008; 7:470 –5. 191. Raymond PD, Hinton-Bayre AD, Radel M, et al. Assessment of statistical change criteria used to define significant change in neuropsychological test performance following cardiac surgery. Eur J Cardiothorac Surg. 2006; 29: 82– 8. 192. Rengo G, Galasso G, Vitale DF, Furgi G, Zincarelli C, Golino L, Femminella GD, Piscione F, Rengo F, Leosco D. An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients. J Gerontol A Biol Sci Med Sci. 2010; 65 (7): 758-63. 182 193. Roose SP, Seidman SN. Sexual activity and cardiac risk: is depression a contributing factor? Am J Cardiol. 2000; 86: 38F– 40F. 194. Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D, Myers MG, Calciu CD, Dalle-Ave S, Martineau P, Mormont C, van Gilst WH; IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation. 2008;117: 24–31. doi:10.1161/CIRCULATIONAHA.106.685073. 195. Rudolph JL, Jones RN, Rasmussen LS, et al. Independent vascular and cognitive risk factors for postoperative delirium. Am J Med. 2007;120: 807–13. 196. Rudolph JL, Babikian VL, Treanor P, et al. Microemboli are not associated with delirium after coronary artery bypass graft surgery. Perfusion. 2009; 24: 409 –15. 197. Ruzyllo W, Szwed H, Sadowski Z, Elikowski W, Grzelak-Szafranska H, Orszulak W, Szymczak K, Winter M. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study. Curr Med Res Opin. 2004; 20(9): 1447-54. 198. Sabik JF 3rd, Blackstone EH, Gillinov AM, Smedira NG, Lytle BW. Occurrence and risk factors for reintervention after coronary artery bypass grafting. Circulation. 2006; 114(suppl): I454–60. doi: 10.1161/CIRCULATIONAHA.105.001149. 199. Sawatzky JA, Kehler DS, Ready AE, Lerner N, Boreskie S, Lamont D, Luchik D, Arora RC, Duhamel TA. Prehabilitation program for elective coronary artery bypass graft surgery patients: a pilot randomized controlled study. Clin Rehabil. 2014; 28 (7): 648-57. 200. Sellier P., Varaillac P., Chatellier G. et al. Investigators of the PERISCOP Study Factors influencing return to work at one year after coronary bypass graft surgery: results of the PERISCOP study. Eur J Cardiovasc Prev Rehabil. 2003; 10: 469-75. 201. Selnes OA, Grega MA, Borowicz LM Jr., et al. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg. 2003;75:1377– 84. 202. Selnes OA, Grega MA, Bailey MM, et al. Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol. 2008;63:581–90. 203. Sharma GV, Khuri SF, Josa M, et al. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.Circulation. 1983; 68: II218 –21. 183 204. Savci S, Degirmenci B, Saglam M, Arikan H, Inal-Ince D, Turan HN, Demircin M. Short-term effects of inspiratory muscle training in coronary artery bypass graft surgery: a randomized controlled trial. Scand Cardiovasc J. 2011; 45 (5): 286-93. 205. Shiran A, Kornfeld S, Zur S, et al. Determinants of improvement in exercise capacity in patients undergoing cardiac rehabilitation. Cardiology. 1997; 88: 207–13. 206. Smith PK, Anderson JL, Bittl JA., et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A Report of the American College of Cardiology Foundation /American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124: e652-e735. 207. Smith JL, Verrill TA, Boura JA, Sakwa MP, Shannon FL, Franklin BA. Effect of cardiorespiratory fitness on short-term morbidity and mortality after coronary artery bypass grafting. Am J Cardiol. 2013; 112 (8): 1104-9. 208. Smith PK, Goodnough LT, Levy JH, Poston RS, Short MA, Weerakkody GJ, Lenarz LA. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. J Am Coll Cardiol. 2012; 60: 388–96. doi: 10.1016/j.jacc.2012.03.030. 209. Sousa-Uva M, Storey R, Huber K, Falk V, Leite-Moreira AF, Amour J, Al-Attar N, Ascione R, Taggart D, Collet J-Ph, on behalf of ESC Working Group on Cardiovascular Surgery and ESC Working Group on Thrombosis Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. Eur Heart J. 2014; 35: 1510–4. doi:10.1093/eurheartj/ehu158. 210. Steingrimsson S, Gottfredsson M, Kristinsson KG, Gudbjartsson T. Deep sternal wound infections following open heart surgery in Iceland:a population-based study. Scand Cardiovasc J. 2008; 42: 208–13. doi:10.1080/14017430801919557. 211. Steinke EE, Jaarsma T, Barnason SA., Byrne M, Doherty S, Dougherty CM., Fridlund B, Kautz DD., Mårtensson J, Mosack V,. Moser DK on behalf of the Council on Cardiovascular and Stroke Nursing of the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). Sexual Counselling for IndividualsWith Cardiovascular Disease and Their Partners. A Consensus Document From the American Heart Association and the ESC Council on 184 Cardiovascular Nursing and Allied Professions (CCNAP). Eur Heart J. 2013; doi:10.1093/eurheartj/eht270. 212. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PWF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129 (suppl2): S1–S45. doi: 10.1161/01.cir.0000437738.63853.7a. 213. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Anesthesiology. 1998; 88: 327–33. 214. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007; 116: 1653-62. 215. Suaya JA., Stason WB., Ades PA., Normand SL., Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J.Am. Coll Cardiol., 2009; 54: 25-33. 216. Sweet JJ, Finnin E, Wolfe PL, et al. Absence of cognitive decline one year after coronary bypass surgery: comparison to nonsurgical and healthy controls. Ann Thorac Surg. 2008; 85:1571-8. doi: 10.1016/j.athoracsur.2008.01.090. 217. Szczepanska-Gieracha J, Morka J, Kowalski J. еt al. The role of depressive and anxiety symptoms in the evaluation of cardiac rehabilitation efficacy after coronary artery bypass grafting surgery. Eur J Cardiothorac Surg. 2012; 42 (5): e108-14. 218. Tabata M., Khalpey Z., Pirundini P.A. et al. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007; 100: 442-4. 219. Takagi H, Tanabashi T, Kawai N, et al. A meta-analysis of minimally invasive coronary artery bypass versus percutaneous coronary intervention with stenting for isolated left anterior descending artery disease is indispensable. J Thorac Cardiovasc Surg. 2007; 134: 548–9. 185 220. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004; 116: 682–92. 221. Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2013;347:f6879. 222. van Domburg RT, op Reimer WS, Hoeks SE, et al. Three life-years gained from smoking cessation after coronary artery bypass surgery: a 30–year follow-up study. Am Heart J. 2008; 156: 473– 6. 223. van DD, Spoor M, Hijman R, et al. Cognitive and cardiac outcomes 5 years after off- pump vs on-pump coronary artery bypass graft surgery. JAMA. 2007; 297: 701– 8. 224. Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg. 2009;109: 320–30. 225. Wang Y, Chen S, Shi J-W, Dong N-G * Benefit and Safety of Dual Antiplatelet Therapy after Coronary Artery Bypass Grafting for Off-pump CABG: A Systematic Review and Meta-analysis Benefit and Safety of Dual Antiplatelet Therapy after Coronary Artery Bypass Grafting for Off-pump CABG: A Systematic Review and Meta- analysis. British Journal of Medicine & Medical Research. 2015; 9(11): 1-15. 226. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure- lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol. 1999; 83: 21–8. 227. Weintraub WS., Grau-Sepulveda MV., Weiss JM., et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012; 366: 1467-76. 228. Werda J.P., Tremoli E., Massironi P. et al. Statins in coronary bypass surgery: rationale and clinical use. Ann Thorac Surg. 2003; 76: 2132-40. 229. West RR., Jones DA., Henderson AH Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomized controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction. Heart, 2012; 98: 637-44. 186 230. Westerdahl E1, Olsén MF. Chest physiotherapy and breathing exercises for cardiac surgery patients in Sweden - a national survey of practice. Monaldi Arch Chest Dis. 201; 75(2):112-9. 231. White CM, Kluger J, Lertsburapa K, et al. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg. 2007; 31:817–20. 232. Wijns W, Kolh Ph, Danchin N, et al. ESC/EACTS Guidelines on myocardial Revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010; 31: 2501–55. 233. Wijeysundera, D.N., Beattie W.S., Djaiani G. et al. Off-pump coronary artery surgery for reducing mortality and morbidity: metaanalysis of randomized and observational studies. J. Am. Coll. Cardiol. 2005; 46: 872–82. 234. Windecker S, Kolh Ph, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial Revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2014; doi:10.1093/eurheartj/ehu278. 235. Wiviott SD, Braunwald E, McCabe CH, et al. for the TRITONTIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357: 2001–15. 236. Wu H, Wang J, Sun H, et al. Preoperative continuation of aspirin therapy may improve perioperative saphenous venous graft patency after off-pump coronary artery bypass grafting. Ann Thorac Surg. 2015; 99 (2): 576-80. 237. Zannad F., McMurray J.J., Krum H., et al. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms. N Engl J Med 2011: 364 (1): 11-21. 238. Zarbock A, Mueller E, Netzer S, et al. Prophylactic nasal continuous positive airway pressure following cardiac surgery protects from postoperative pulmonary complications: a prospective, randomized, controlled trial in 500 patients. Chest. 2009; 135: 1252–9. 239. Zhang Z, Xu G, Liu D, ZhuW, Fan X, Liu X. Dietary fiber consumption and risk of stroke. Eur J Epidemiol 2013; 28:119–30. 187 240. Zhang H, Yuan X, Zhang H, Chen S, Zhao Y, Hua K, Rao C, Wang W, Sun H, Hu S, Zheng Z Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long- Term Outcomes After Coronary Artery Bypass Grafting Surgery Circulation. 2015; 131: 2194-201. doi: 10.1161/CIRCULATIONAHA.114а.014209. 241. Zhang N, Lei J, Liu Q, Huang W, Xiao H, Lei H. The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis. Cardiology. 2015; 131(2): 86-96. 242. Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Eur J Cardiothorac Surg. 2005; 27: 606–10. 243. Yang Z, Kozai T, van der Loo B, Viswambharan H, Lachat M, Turina MI, Malinski T, Lьscher TF. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. J Am Coll Cardiol. 2000; 36: 1691–7. 244. Yao B, Fang H, XuW, Yan Y, Xu H, Liu Y, Mo M, Zhang H, Zhao Y. Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. Eur J Epidemiol. 2014; 29: 79–88. |